2017 Annual Meeting

Session: Model Based Integrated Design of Pharmaceutical Drug Substance Processes I

This session seeks contributions showcasing the development and implementation of first-principles as well as data-driven process modeling, simulation and optimization methods for design and development of pharmaceutical processes for the production of key intermediates and APIs. Modeling approaches including CFD, DEM, FEM, PBM, Monte Carlo and other methods, or a focus on thermodynamic, kinetic and transport parameter estimation, are welcome. Authors are encouraged to highlight Quality by Design (QbD) mapping approaches, process integration and intensification achievements, process economics and environmental impact analyses.

Chair

Yuesheng Ye, Food and Drug Administration

Co-Chair

Marimuthu Andiappan, Oklahoma State University

Presentations

08:00 AM

08:25 AM

08:50 AM

Edward Conder, Carla Luciani, Jonas Y. Buser, Jeffrey Tan, Adam D. McFarland, Matthew C. Embry, Scott A. May, Mark S. Kerr, Luke Webster

09:15 AM

Maitraye Sen, Salvador Garcia-Munoz, Nil Tandogan, Indrakant V. Borkar, Stanley P. Kolis, Thomas M. Wilson, Jonas Y. Buser, Charles A. Alt

09:40 AM

10:05 AM

Kushal Sinha, Nandkishor Nere, John G. Gaertner, Laurie Mlinar, Raimundo Ho, Alessandra Mattei, Haojuan Wei, Samrat Mukherjee, Ahmad Sheikh, Shailendra Bordawekar